SG11201604786QA - Polymorphic and amorphous forms of cortisol 17-alpha-benzoate and methods for the preparation and use thereof - Google Patents

Polymorphic and amorphous forms of cortisol 17-alpha-benzoate and methods for the preparation and use thereof

Info

Publication number
SG11201604786QA
SG11201604786QA SG11201604786QA SG11201604786QA SG11201604786QA SG 11201604786Q A SG11201604786Q A SG 11201604786QA SG 11201604786Q A SG11201604786Q A SG 11201604786QA SG 11201604786Q A SG11201604786Q A SG 11201604786QA SG 11201604786Q A SG11201604786Q A SG 11201604786QA
Authority
SG
Singapore
Prior art keywords
cortisol
polymorphic
benzoate
alpha
preparation
Prior art date
Application number
SG11201604786QA
Other languages
English (en)
Inventor
Shaoxin Feng
Scott W Smith
Olivier M G Lambert
Suzanne Buttar
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52293229&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201604786Q(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of SG11201604786QA publication Critical patent/SG11201604786QA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11201604786QA 2013-12-13 2014-12-12 Polymorphic and amorphous forms of cortisol 17-alpha-benzoate and methods for the preparation and use thereof SG11201604786QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361915589P 2013-12-13 2013-12-13
PCT/US2014/070147 WO2015089471A2 (en) 2013-12-13 2014-12-12 Polymorphic forms of a steroid-like compound and methods for the preparation and use thereof

Publications (1)

Publication Number Publication Date
SG11201604786QA true SG11201604786QA (en) 2016-07-28

Family

ID=52293229

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201604786QA SG11201604786QA (en) 2013-12-13 2014-12-12 Polymorphic and amorphous forms of cortisol 17-alpha-benzoate and methods for the preparation and use thereof
SG10201709987QA SG10201709987QA (en) 2013-12-13 2014-12-12 Polymorphic and amorphous forms of cortisol 17-alpha-benzoate and methods for the preparation and use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201709987QA SG10201709987QA (en) 2013-12-13 2014-12-12 Polymorphic and amorphous forms of cortisol 17-alpha-benzoate and methods for the preparation and use thereof

Country Status (17)

Country Link
US (1) US10065984B2 (es)
EP (1) EP3080140A2 (es)
JP (1) JP2016540001A (es)
KR (1) KR20160098338A (es)
CN (1) CN105814071A (es)
AR (1) AR098747A1 (es)
AU (1) AU2014361790B2 (es)
CA (1) CA2933371A1 (es)
CL (1) CL2016001429A1 (es)
IL (1) IL246059A0 (es)
MX (1) MX371012B (es)
PH (1) PH12016501098A1 (es)
SA (1) SA516371308B1 (es)
SG (2) SG11201604786QA (es)
TW (1) TWI659041B (es)
UA (1) UA121203C2 (es)
WO (1) WO2015089471A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019055028A1 (en) * 2017-09-15 2019-03-21 Kala Pharmaceuticals, Inc. PARTICLES, COMPOSITIONS AND METHODS FOR OPHTHALMIC APPLICATIONS AND / OR OTHER APPLICATIONS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6605514A (es) * 1966-04-25 1967-10-26
IT1056711B (it) * 1967-04-01 1982-02-20 Vismara F Spa Derivati dell idrocortisone
JPS52136157A (en) 1976-04-14 1977-11-14 Taisho Pharmaceut Co Ltd Preparation of steroid 17-esters
JPS54151958A (en) * 1978-05-19 1979-11-29 Taisho Pharmaceut Co Ltd Preparation of pregnane steroid 17alpha-ester
US8501800B2 (en) * 2009-03-05 2013-08-06 Insite Vision Incorporated Controlled-release ophthalmic vehicles
EP2619205B1 (en) * 2010-09-23 2017-05-17 AbbVie Bahamas Ltd. Monohydrate of an azaadamantane derivative
UA111867C2 (uk) * 2011-11-11 2016-06-24 Аллерган, Інк. ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ І СПОСІБ ЗАСТОСУВАННЯ ПОХІДНИХ 4-ПРЕГНЕН-11β-17-21-ТРІОЛ-3,20-ДІОНУ
CA2873214C (en) * 2012-05-11 2021-02-16 Reset Therapeutics, Inc. Carbazole-containing sulfonamides as cryptochrome modulators

Also Published As

Publication number Publication date
SA516371308B1 (ar) 2019-07-08
MX2016007718A (es) 2016-09-09
WO2015089471A3 (en) 2015-11-19
KR20160098338A (ko) 2016-08-18
CA2933371A1 (en) 2015-06-18
TWI659041B (zh) 2019-05-11
MX371012B (es) 2020-01-10
EP3080140A2 (en) 2016-10-19
CN105814071A (zh) 2016-07-27
AU2014361790A1 (en) 2016-07-07
AU2014361790B2 (en) 2019-05-23
AR098747A1 (es) 2016-06-08
US10065984B2 (en) 2018-09-04
SG10201709987QA (en) 2018-01-30
TW201609788A (zh) 2016-03-16
CL2016001429A1 (es) 2016-12-23
UA121203C2 (uk) 2020-04-27
JP2016540001A (ja) 2016-12-22
IL246059A0 (en) 2016-07-31
PH12016501098A1 (en) 2016-08-15
WO2015089471A2 (en) 2015-06-18
US20150166597A1 (en) 2015-06-18

Similar Documents

Publication Publication Date Title
IL280155A (en) Anti- SIGLEC-8 antibodies and methods of using them
IL290547A (en) Antibodies and methods of use
IL244495B (en) Anti-alpha-synuclein antibodies and methods of use
GB2535360B (en) Methods of preparing polyhemiaminals and polyhexahydrotriazines
HRP20170840T4 (hr) Supstituirani ksantini i metode njihove uporabe
HK1217708A1 (zh) 新的雷公藤甲素衍生物及其製備方法和用途
HK1225612A1 (zh) 抗ly6e抗體及使用方法
HK1218388A1 (zh) 奧那司酮多晶型形式和使用方法
IL246059A0 (en) Polymorphic and amphoteric forms of cortisol 17-alpha-benzoate and methods for their preparation and use